Cat 2 CME Report Print Save
  • Facebook
  • LinkedIn
  • Twitter
  • Google Plus
  • Email

Advertisement

A combination of recombinant BCG expressing pneumococcal proteins induces cellular and humoral immune responses and protects against pneumococcal colonization and sepsis

Clinical and Vaccine Immunology

August 03, 2017

Goulart C, et al.

In order to find out if a combination of recombinant BCG expressing pneumococcal proteins induces cellular and humoral immune responses and protects against pneumococcal colonization and sepsis, experts conduct this study. The use of combined rBCG strains as a potentially serotype– transcending pneumococcal vaccine in a prime–boost strategy, has been proposed. It appears to provide protection against pneumococcal colonization and sepsis.
Read the full article on Clinical and Vaccine Immunology.

Advertisement

Advertisement

Advertisement

Advertisement

Featured Articles

In the News

Microstructural bone changes biomarker for autoimmunity and RA

In the News

Residents can be sued, too: Experts offer mitigation strategies

In the News

SLE and antiphospholipid antibody syndrome as risk factors for acute coronary...

In the News

The importance of women supporting women in medicine

In the News

Targeting long-haul COVID: An exclusive interview on the latest research

In the News

Successfully navigating state licensure as a resident

In the News

The leap from residency to fellowship: How to apply and interview

In the News

Biologic therapy in pediatrics: Focus on dermatology and rheumatology

In the News

'Step away'—When patients make you furious

In the News

Residents should set these 3 financial priorities

In the News

How to combat sexual harassment in medicine

In the News

Pregnancy during residency? It’s possible, but keep these factors in mind

  • 1
  • 2
  • 3
  • 4
  • 5
  • Last

We Recommend For You

  1. Is use of procalcitonin effective for selecting antibiotic regimens in outpatients...

    In the News

  2. Pneumococci evade the immune response thanks to autolysin-assisted capsule...

    In the News

  3. What's new for pneumonia? Five innovative antibiotics in the pipeline

    In the News

    4. Advertisement

  4. Survivors of invasive pneumococcal pneumonia may suffer shorter lifespans

    In the News

  5. Childhood deaths attributable to invasive pneumococcal disease in England and...

    Journal Article

  6. A combination of recombinant BCG expressing pneumococcal proteins induces cellular...

    Journal Article

  7. Assessing the diagnostic accuracy of PCR-based detection of Streptococcus...

    Journal Article

  8. Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects...

    Clinical Trial

  9. Celiac disease and increased risk of pneumococcal infection: A systematic review...

    Journal Article

  10. Conference on Retroviruses and Opportunistic Infections (CROI)

    Conference

Sign In

Don't Have Account? Sign Up here.

Password Help

Enter your email address and a password reset email will be sent to you.

or

Log In with Facebook Log In with Google Log In with LinkedIn

Verification

Please submit one of the following:

  • Copy of license
  • Copy of medical school diploma
  • Office website
    (website address should include physician name, medical school, grad year)
Submit to Support@MDLinx.com

— Action Required —

Your browser is currently blocking ads. We depend on ad sponsorships in order to keep this site free to the healthcare provider community. Help us keep this site free by turning off your ad blocker.

Turn Off Ad Blocker

We have detected that you are currently blocking ads. We kindly ask that you enable ads when visiting our site. We depend on ad sponsorships in order to keep this site free to the healthcare provider community.